ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223 | -11.9% | 8,220 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $253 | -15.4% | 8,220 | -0.9% | 0.01% | -18.2% |
| Q1 2023 | $299 | -8.8% | 8,293 | 0.0% | 0.01% | -8.3% |
| Q4 2022 | $328 | -99.9% | 8,293 | +1.1% | 0.01% | 0.0% |
| Q3 2022 | $330,000 | -2.7% | 8,203 | +1.8% | 0.01% | -7.7% |
| Q2 2022 | $339,000 | +59.9% | 8,058 | +48.3% | 0.01% | +85.7% |
| Q1 2022 | $212,000 | +26.2% | 5,434 | +28.9% | 0.01% | +16.7% |
| Q4 2021 | $168,000 | +78.7% | 4,216 | +61.3% | 0.01% | +100.0% |
| Q3 2021 | $94,000 | -21.7% | 2,614 | -10.8% | 0.00% | -25.0% |
| Q2 2021 | $120,000 | – | 2,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |